Delphyr
About Delphyr
Delphyr provides an AI-driven clinical copilot that integrates with existing EHR systems to surface real-time, summarized patient data via natural language queries. This platform automates administrative documentation, significantly reducing clinician workload and improving access to comprehensive patient information. Delphyr utilizes a purpose-built medical LLM hosted on its own infrastructure to ensure data sovereignty and regulatory compliance.
<problem>Healthcare professionals spend a large portion of their time—up to 40%—on administrative tasks and searching fragmented electronic health record (EHR) data. This “data noise” and “data scatter” leads to inefficient workflows and limits clinicians’ ability to access all relevant patient information quickly.</problem> <solution>Delphyr provides an AI‑driven clinical copilot that integrates directly with existing hospital information systems to surface patient data in real time. Users can ask natural‑language questions and receive concise, evidence‑based answers that summarize labs, imaging, notes, and medication histories. The platform automates routine documentation and administrative workflows, reducing manual effort by up to 90% and giving clinicians up to half a day back each week. Its purpose‑built medical large language model runs on Delphyr’s own infrastructure, ensuring full control over privacy, security, and compliance with European AI regulations.</solution> <features> - Real‑time extraction and summarization of patient data from chaotic EHR systems. - Natural‑language query interface that returns concise clinical insights and evidence‑based guidelines. - Automated generation of clinical notes and documentation to cut administrative workload. - Seamless integration into existing clinician workflows without requiring new software stacks. - Purpose‑built medical large language model hosted on Delphyr’s own infrastructure for full data sovereignty. - Privacy‑focused architecture with end‑to‑end encryption and compliance with EU AI and MDR regulations. - Hospital‑wide access to a unified patient view, eliminating information silos across teams. </features> <target_audience>Delphyr is aimed at doctors, nurses, and other frontline clinicians, as well as hospitals seeking to improve staff efficiency and patient outcomes through AI‑enhanced data access.</target_audience> <traction>Delphyr secured its first customer in the Netherlands shortly after launch and has since run pilots such as the Dutch Endometriosis Center (Oct 2025). It announced a partnership with Reinier de Graaf Hospital (Jan 2024) and won the STZ Innovation Challenge (2025). Ongoing beta programs and multiple blog announcements demonstrate active adoption and validation across European healthcare providers.</traction> <sources> - https://www.leapfunder.com/round/delphyr-1876 - https://aic4nl.nl/en/deelnemers/delphyr/ - https://delphyr.ai/for-doctors-and-nurses - https://delphyr.ai/for-hospitals - https://delphyr.ai/about-us - https://www.delphyr.ai/blog/pilot-the-dutch-endometriosis-center - https://www.delphyr.ai/blog/ai-copilot-for-doctors - https://www.delphyr.ai/blog/inh-investment - https://www.delphyr.ai/blog/partnership-rdgg - https://www.delphyr.ai/blog/delphyr-wins-stz-innovation-challenge </sources>
What does Delphyr do?
Delphyr provides an AI-driven clinical copilot that integrates with existing EHR systems to surface real-time, summarized patient data via natural language queries. This platform automates administrative documentation, significantly reducing clinician workload and improving access to comprehensive patient information. Delphyr utilizes a purpose-built medical LLM hosted on its own infrastructure to ensure data sovereignty and regulatory compliance.
Where is Delphyr located?
Delphyr is based in IJsbaanpad 2 Amsterdam, Netherlands.
When was Delphyr founded?
Delphyr was founded in 2023.
How much funding has Delphyr raised?
Delphyr has raised 289100.
- Location
- IJsbaanpad 2 Amsterdam, Netherlands
- Founded
- 2023
- Funding
- 289100
- Employees
- 9 employees
- Major Investors
- Innovatiefonds Noord-Holland